Investing

Syros Pharmaceuticals : SYRS

SYRS

Stock Data

$0.00

$0.00 (125.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Syros Pharmaceuticals Inc is a pioneering biopharmaceutical firm based in Cambridge, Massachusetts, dedicated to developing innovative treatments for blood cancers. Its leading products include Tamibarotene, aimed at certain myelodysplastic syndrome patients and acute myeloid leukemia, SY-2101 for acute promyelocytic leukemia, and SY-5609 for advanced solid tumors. The company, established in 2011, collaborates with Incyte Corporation and TMRC Co. Ltd. to advance its research and bring new therapies to market.

All Syros Pharmaceuticals Articles

1 Article

Trey Thoelcke | Dec 31, 2023 at 10:10 AM EST

Here’s What Insiders Are Buying to Wrap Up the Year

As the year wound to a close, the most notable insider buying was focused on biotech stocks, but an oil…